N-(4-(2-chloro-4-(trifluoromethyl)phenoxy)phenyl)picolinamide as a new inhibitor of mitochondrial complex III: Synthesis,biological evaluation and computational simulations

Mitochondrial complex III is one of the most promising targets for a number of pharmaceuticals and fungicides. Due to the wide-spread use of complex III-inhibiting fungicides, a considerable increase of resistance has occurred worldwide. Therefore, inhibitors with novel scaffolds and potent activity against complex III are still in great demand. In this article, a new series of amide compounds bearing the diaryl ether scaffold were designed and prepared, followed by the biological evaluation. Gratifyingly, several compounds demonstrated potent activity against succinate-cytochrome c reductase (SCR, a mixture of mitochondrial complex II and complex III), with compound 3w possessing the best inhibitory activity (IC₅₀ = 0.91 ± 0.09 μmol/L). Additional studies verified that 3w was a new inhibitor of complex III. Moreover, computational simulations elucidated that 3w should bind to the Q_o site of complex III. We believe this work will be valuable for the preparation and discovery of more complex III inhibitors.     

Synthesis and anomalous magnetic properties of heterometal dinuclear Fe(II)-Cr(III) complex bridged by 3,5-bis(pyridin-2-yl)-pyrazolate

A Cr(III)-Fe(II) dinuclear complex [(nta)Cr(μ-bpypz)Fe(dpea)]BF₄, where bpypz=3,5-bis(pyridin-2-yl)-pyazolate, nta=nitrilotriacetate and dpea=(2-aminoethyl)-bis(2-pyridylmethyl)amine, has been synthesized and structurally characterized by ESI-MS and ²H NMR spectra. The proposed structure is mostly more planar in the bridging moiety as compared to that of the previously reported [(nta)Cr(μ-bpypz)Fe(picen)]BF₄(N,N^′-bis-(2-pyridylmethyl)ethylenediamine(picen)). The dpea complex is found to be a high spin state, but to exhibit no spin-crossover by magnetic susceptibility and Mössbauer spectra measurements; showing a large antiferromagnetic interaction, which could make the spin transition temperature lower and/or destroy spin-crossover, suggesting complementarity between spin-crossover and magnetic interaction.     

A novel dinuclear nickel (II) complex: spectroscopic and magnetic studies

A novel dinuclear [(MeOH)(L) Ni (di-μ-CCl₃CO₂) Ni (L)(CCl₃CO₂)] 1 [where L={(O⁻)(C₆H₄CH=NCH₂CH₂NMe₃)}] complex has been synthesized and characterized. Characterization based on elemental analyses, infrared and electronic spectra, thermal studies, variable temperature magnetic susceptibility measurement and crystal structure analysis. The complex crystallizes in the monoclinic system, space group P2(1)/n with a=16.818(11), b=20.386(11), c=20.589(13), β=90.94(5) and Z=8. The complex shows di-μ-trichloroacetate bridging with concatenated methanol molecule hydrogen bonded with another trichloroacetate. Magnetic susceptibility measurements of complex 1 reveal an antiferromagnetic intra-dimer interaction with the J value deduced from the spin Hamiltonian H=−JS₁S₂.     

One trinuclear copper(II) complex derived from a new Schiff base ligand based on the dianion of 4-chloro-6-(hydroxymethyl)-2-((3-aminopropylimino)methyl)-phenol: Synthesis, structure, spectroscopic and magnetic properties

A linear trinuclear copper(II) complex (1), prepared from a new Schiff base ligand, namely the dianion of 4-chloro-6-(hydroxymethyl)-2-((3-aminopropylimino)methyl)-phenol, was synthesized and characterized in this paper. The X-ray structural study reveals that the geometry of the central Cu2 ion is elongated octahedral and that of the two side Cu(II) ions is distorted square pyramidal. The magnetic susceptibility measurements from 2 to 300 K reveal medium antiferromagnetic interactions between the Cu(II) ions with a J value of −64.6(1) cm⁻¹.     

A novel tetranuclear lanthanide(III)-copper(II) complex of the macrocyclic oxamide [PrCu3] (macrocyclic oxamide = 1,4,8,11-tetraazacyclotradecanne-2,3-dione): synthesis, structure and magnetism

A novel tetranuclear lanthanide(III)-copper(II) complex of macrocyclic oxamide, [Pr(CuL)₃(H₂O)₂](SCN)₃ · 1.5H₂O (L = 1,4,8,11-tatraazacyclotradecanne-2,3-dione) (1), has been synthesized, structurally characterized and preliminary investigated by magnetic studies. The structure of the title complex consists of a cationic PrCu₃ core, noncoordinated monovalent SCN⁻ anions and H₂O molecules; the packing diagram shows open channels formed through intermolecular weak interactions. The temperature-dependent magnetic susceptibilities were analyzed by an approximate treatment being enlightened by Matsumoto et al. leading to J = −1.62 × 10⁻² cm⁻¹, Δ = 3.12 cm⁻¹, g_Cu = 2.13, respectively.     

Anticancer activity, structure, and theoretical calculation of N-(1-phenyl-3-methyl-4-propyl-pyrazolone-5)-salicylidene hydrazone and its copper(II) complex

The pyrazolone derivative N-(1-phenyl-3-methyl-4-propyl-pyrazolone-5)-salicylidene hydrazone (H₂L) and its copper(II) complex [Cu₂L₂CH₃OH]·2CH₃OH have been both synthesized and characterized by elemental analyses, IR spectroscopy, X-ray crystallography, theoretical calculation and pharmacological testing. It’s found that the Cu(II) complex possesses more powerful anticancer effectivity than that of the ligand. In order to make its anticancer principium clearly, we investigate their structures. In ligand there are several coordination spots, such as N, O atoms, which are close to biological environment. The crystallographic structural analysis of the complex reveals that the two Cu centers display two different coordination patterns. O1, O2, N3, and N4 from the ligand take part in the coordination with Cu atoms, resulting in the formation of the double-nuclear complex. The pharmacological testing results show that the coordination effect improves the antitumor activity of the ligand. The calculated Fukui function for H₂L and its deprotonated form L²⁻ predicts that the most probable reactive sites for electrophilic attack are oxygen atoms. The result is agreement well with the experimental data of the crystal structure analyses.     

Ruthenium(II) mixed-ligand complex containing 2-(4'-benzyloxy-phenyl)imidazo[4,5-f][1,10]phenanthroline: synthesis, DNA-binding and photocleavage studies

A novel polypyridyl ligand 2-(4'-benzyloxyphenyl)imidazo[4,5-f][1,10]phenanthroline (BPIP) and its complex [Ru(bpy)2(BPIP)]2+ (1) (bpy=2,2'-bipyridine) and (2) [Ru(phen)2(BPIP)]2+) (phen=1,10-phenanthroline) have been synthesized and characterized by elemental analysis, electrospray mass spectra and 1H NMR. The DNA-binding properties of the two complexes were investigated by spectroscopic and viscosity measurements. The results suggest that both complexes bind to DNA via an intercalative mode. Both complexes can enantioselectively interact with calf thymus DNA (CT-DNA) in a way. The Lambda enantiomer of complex 1 is slightly predominant for binding to CT-DNA to the Delta enantiomer. Under irradiation at 365 nm, both complexes have also been found to promote the photocleavage of plasmid pBR 322 DNA. Inhibitors studies suggest that singlet oxygen ((1)O2) and hydroxyl radical (*OH) play a significant role in the cleavage mechanism for both complexes. Moreover, the DNA-binding and photocleavage properties of both complexes were compared with that of [Ru(bpy)2(BPIP)]2+ and [Ru(phen)2(BPIP)]2+. The experimental results indicate that methene group existence or not have a significant effect on the DNA-binding and cleavage mechanism of these complexes.     

Spectral and structural studies of a new oxalato-bridged dinuclear copper(II) complex having two 3-(thiophen-2-yl)-1,10-phenanthroline ligands in a trans configuration

In this paper, spectral and structural characterizations of a new dinuclear copper(II) complex (1), formulated as [Cu₂(3-(thiophen-2-yl)-1,10-phenanthroline)₂(μ-oxalate)(DMF)₂](ClO₄)₂ (DMF = N,N′-dimethylformamide), have been described. Two five-coordinate copper(II) centers are bridged by a four-dentate oxalate dianion forming a planar molecular geometry with the Cu-Cu separation of 5.117(4) Å. The two ligands in 1 adopt a trans configuration to each other and two monodentate DMF molecules are positioned at each side of the molecular plane. In addition, typical π-π stacking interactions are found between adjacent phenanthroline and thiophene rings forming a layered packing structure. A compressed pyramidal configurational alteration is observed for each copper(II) center when the temperature is decreased from 291(2) to 100(2) K.     

A new copper(II) complex of unsymmetrical tetradentate ligand generated in situ: synthesis and molecular structure

A new copper(II) complex with tetradentate unsymmetrical ligand was prepared by one-pot condensation of methyl-2-pyrrole carboxylate, diethylenetriamine and copper(II) sulfate. The complex was characterized by elemental analysis, electronic and IR spectral, as well as X-ray crystal structure determination. The X-ray structure of the molecule reveals the copper(II) center is in a square planar environment through coordination by two nitrogen atoms of the amine, one amide nitrogen atom and one nitrogen atom of the pyrrole moieties, respectively. The copper(II) complex is neutral due to deprotonation of the amide and pyrrole groups.     

A new blue luminescent dichlorido-bridged dinuclear copper(II) complex with DNA binding and cytotoxic activities: Synthesis, structure and DFT studies

A blue luminescent dichlorido-bridged dinuclear copper(II) (S = 1/2) complex, [Cu^II₂(HL)₂(μ-Cl)₂]·2H₂O, 1a was synthesized with the 1:1 reaction of the acyclic tridentate salicylaldehyde 2-pyridyl hydrazone ligand, HL, 1. The complex 1a displays multiple bands in the visible region (400-470 nm). The association constant (K_ass, UV-Vis) was found to be 1.186 × 10⁴ for 1a at 298 K. The copper(II)-copper(III) oxidation potential lies near 0.32 V versus Ag/AgCl electrode. On excitation at 390 nm, the ligand 1 strongly emits at 444 nm due to an intraligand ¹(π-π^∗) transition. Upon complexation with copper(II) the emission peak is slightly red shifted (λ_ex 390 nm, λ_em 450 nm, F/F₀ 0.81) with little quenching. Molecular structure of 1a (Cu···Cu 3.523 Å) has been determined by single crystal X-ray diffraction studies. DFT and TDDFT calculations strongly support the spectral behavior of the ligand and the complex. The complex 1a exhibits a strong interaction towards DNA as revealed from the K_b (intrinsic binding constant) 2.05 × 10⁴ M⁻¹ and K_sv (Stern-Volmer quenching constant) 2.47 values. The complex exhibits cytotoxic effect and the LD₅₀ value for HeLa cells was calculated as 5.44 μM at which the cell cycle was arrested at G₂/M phase.     

A new Schiff base copper (II) complex derived from estrone and d-glucosamine: Synthesis,characterization and its interaction with DNA

A novel copper (II) complex of Schiff base prepared through condensation between 2-formyl-17-deoxyestrone and d-glucosamine was synthesized and characterized. Fluorescence spectroscopy was conducted to assess their binding ability with CT-DNA. The results showed that the copper (II) complex could bind to DNA with a weak intercalative mode. The interaction between the copper (II) complex and DNA was also investigated by gel electrophoresis. Interestingly, we found that the complex could cleave plasmid DNA (pUC19) to nicked and linear forms through an oxidative mechanism without the use of exogenous agents.     

Azo-containing pyridine amide ligand. A six-coordinate nickel(II) complex and its one-electron oxidized species: Structure and properties

A new potentially tridentate ligand HL¹¹ consisting of 2-pyridinecarboxamide unit and azo functionality has been used, in its deprotonated form, to prepare a nickel(II) complex which has been structurally characterized. The ligand L¹¹(−) affords a bis-complex [Ni^II(L¹¹)₂] (1). In 1, the two L¹¹(−) ligands bind to the Ni^II center in a mer configuration. The relative orientations within the pairs of pyridyl-N, deprotonated amido-N, and azo-N atoms are cis, trans, and cis, respectively. The Ni^IIN₂(pyridyl)N′₂(amide)N″₂(azo) coordination environment is severely distorted from ideal octahedral geometry. The Ni-N_am (am = amide) bond lengths are the shortest and the Ni-N_azo bond lengths are the longest. Complex 1 exhibits a quasireversible Ni^III/Ni^II redox process. Moreover, the complex displays two ligand-centered (azo group) quasireversible redox processes. Spectroscopic (absorption and EPR) properties have been studied on coulometrically-generated nickel(III) species. To understand the nature of metal-ligand bonding interactions Density Functional Theory (DFT) calculations have been performed on 1 at the B3LYP level of theory. Calculations have also been done for closely related nickel(II) complexes of deprotonated pyridine amide ligands and comparative discussion has been made using observed results.     

Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II

The X-ray crystal structures of 5-amino-1,3,4-thiadiazole-2-sulfonamide (the acetazolamide precursor) and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide in complex with the human isozyme II of carbonic anhydrase (CA, EC 4.2.1.1) are reported. The thiadiazole-sulfonamide moiety of the two compounds binds in the canonic manner to the zinc ion and interacts with Thr199, Glu106, and Thr200. The substituted phenyl tail of the second inhibitor was positioned in the hydrophobic part of the binding pocket, at van der Waals distance from Phe131, Val 135, Val141, Leu198, Pro202, and Leu204. These structures may help in the design of better inhibitors of these widespread zinc-containing enzymes.     

The use of trans-4-cotininecarboxylate to construct a polymeric copper(II) azido complex: Hydro(solvo)thermal synthesis, structure and magnetic properties

A new pyridyl-carboxylate ligand, the anion of trans-4-cotininecarboxylic acid, HL, 1, has been used to prepare a new polymeric copper(II) complex, [CuLN₃]_2n, 2, based on a [CuLN₃]₂ dimeric building block. The single crystal structures of both 1 and 2 have been determined and 1 has been found to be in its zwitterionic configuration. The structure of 2 is a one-dimensional tape-like polymeric structure based on an end-on azido-bridged binuclear [Cu₂N₃]₂ backbone moiety. Magnetic studies reveal that 2 is close to paramagnetic from 2 to 300 K with a Curie constant of 1.094 emu K/mol, a Weiss temperature of 0.73 K and a corresponding μ_eff of 2.09 μ_B. A fit of χ_MT for 2 with S₁ = S₂ = ½, yields g = 2.441(6), J = −0.49(3) cm⁻¹, zJ = −0.38(2) cm⁻¹ and N(α) = 0.00053(12) emu/mol, a fit that indicates the presence of both very weak intramolecular intrachain antiferromagnetic exchange coupling within the one-dimensional tape-like chains and very weak interchain antiferromagnetic exchange coupling between these chains.     

Synthesis and physicochemical characterization of oxo and phenylimido Re(V), Re(III) and Ni(II) complexes with the 2-[bis(ethoxyethyl)phosphino]phenolato ligand and derivatives

2-[Bis(ethoxyethyl)phosphino]phenol P¹-OH reacts in basic refluxing solvents with ReOCl₃(PPh₃)₂, in a 2/1 molar ratio, to give the green ReOCl(P¹-O)₂ complex. Structure elucidation by ³¹P NMR is consistent with a cis-PP “twisted” octahedral complex, which is the preferred conformation on electronic grounds. The complex is unique in toluene while several species were present in ethanol. When the reaction is performed with Re(NPh)Cl₃(PPh₃)₂, a mixture of trans-PP (major) and cis-PP(minor) species in a 3/1 ratio is obtained. These geometric isomers were distinguished by their ²J_PP coupling constants. Only cis-PP-Re(NPh)Cl(P¹-O)₂, less soluble, could be isolated and its molecular structure determined by physicochemical measurements. This is the first example of cis-PP phosphinophenolato complex with the [ReNPh]³⁺ core, thus illustrating the importance of the steric demand of the phosphine substituent. Reaction of P¹-OH with NiCl₂ gives Ni(P¹-O)₂ as an orange oily solid with a cis-PP square planar structure. This structure is the most probable based on the ³¹P, ¹³C NMR data.     

Synthesis, solid-state characterization and antimicrobial activities of three different polymorphs of a copper(II) complex with 4-isopropyltropolone (hinokitiol)

There exist at least three different polymorphs in the copper(II) complex [Cu(hino)₂] with a hinokitiol ligand (Hhino; 4-isopropyltropolone¹). In addition to deep-green plate crystals 1a and deep-green rod crystals 1b, whose crystal structures have been recently reported, novel green needle crystals 1c of [Cu(hino)₂] were found, the crystal structure of which was here determined by single-crystal X-ray analysis. Since only one crystal structure has been reported for the copper(II) complex [Cu(trop)₂] with a tropolone ligand (Htrop), the polymorphism found in the crystals of [Cu(hino)₂] would be due to the presence of the isopropyl group on the tropolone ring. The synthetic conditions giving the three polymorphs in good yields were found and the crystals were characterized with elemental analysis, FT-IR, TG/DTA and X-ray powder diffraction (XPD) measurements, as well as solution molecular weight measurements for 1a. The solid-state magnetic behaviors or the temperature-dependent magnetic susceptibilities were measured with Superconductivity Quantum Interference Devices (SQUID): 1a showed a weak ferromagnetic interaction, 1b showed a paramagnetic nature with S=1/2, while 1c showed a weak antiferromagnetic interaction. The antimicrobial activities for selected bacteria, yeasts and molds were also measured in the water-suspension system: 1a and 1b showed no activity, while 1c showed modest activities, and these activities were compared with those of the neutral Hino and the anionic hino⁻ ligands.     

Synthesis and characterization of an N-coordinated amidate copper(II) complex of deprotonated N-(2,6-diisopropylphenyl)-2-(bis-(2-pyridylmethyl))aminoethanamide

The title ligand, N-(2,6-diisopropylphenyl)-2-(bis-(2-pyridylmethyl))aminoethanamide (DIPMAE-H), was prepared by a nucleophilic substitution reaction between N-(2,6-diisopropyl)phenyl-2-bromoethanamide and bis-(2-pyridylmethyl)amine. An analogous ligand (TBPMAE-H) in which the 2,6-diisopropylphenyl group was substituted for a tert-butyl group was also prepared in this manner. Then, [(DIPMAE-H)CuBr]⁺Br⁻ and [(TBPMAE-H)CuBr]⁺Br⁻ were prepared by heating one equivalent of ligand and CuBr₂ in CH₃CN. In both compounds the geometry about the copper center is square pyramidal with distortions due to the geometrical constraints of the ligand. The amide oxygen occupies the axial position, and the three amine nitrogens and the bromide ligand form the basal plane of the square pyramid. Pairs of complexes in the unit cell are associated via weak donation of a lone pair on the bromide ligand of one complex to the copper center of another (Cu?Br distances in the range of 3.3576-3.4022 Å).The title compound, (DIPMAE)CuBr, was prepared by deprotonation of [(DIPMAE-H)CuBr]⁺Br⁻ using NaH. The key feature of (DIPMAE)CuBr is the amidate group η¹- and N-coordinated to the copper center. The compound also exhibits distorted trigonal bipyramidal coordination geometry with the bromide and tertiary amine donors occupying the axial sites and the amidate and pyridyl donors occupying the equatorial positions. The copper atom is displaced from the trigonal plane towards the bromide donor apex due to the geometrical demands of the ligand.     

Probing the biological evaluations of a new designed Pt(II) complex using spectroscopic and theoretical approaches: human hemoglobin as a target

In recent years, using heavy metal compounds such as platinum as anticancer agent is one of the common ways in chemical therapy. In this study, a new anticancer compound of glycine derivatives of Pt(II) complex (amyl-glycine1, 10-phenanthroline Platinum nitrate) was designed, and the biological effects of this novel compound on the alterations in the function and structure of human hemoglobin (Hb) at different temperatures of 25 and 37°C were assessed by applying various spectroscopic (fluorescence and circular dichroism (CD)) and theoretical methods. Fluorescence data indicated the strong ability of Pt(II) complex to quench the intrinsic fluorescence of Hb. The binding constant, number of binding sites, and thermodynamic parameters at two temperatures were calculated, and the results indicated the major possibility of occurring van der Waals force or hydrogen bond interactions in the Pt(II) complex–Hb interaction. For evaluating the alteration of secondary structure of Hb upon interaction with various concentrations of complex, far-UV CD spectra were used and it was observed that in high dose of complex, significant changes were occurred which is indicative of some side effects in overdosing of this complex. On the other hand, the molecular docking results illustrate that are well in agreement in obtaining data with spectroscopy. Above results suggested that using Pt(II) complex as an anticancer agent, model drug in high-dose usage might cause some disordering in structure and function of Hb as well as improve understanding of the side effects of newly designed metal anticancer drugs undergoing.     

Sterically-controlled nuclearity in new copper(II) complexes with di-compartmental ligands: Formation of antiferromagnetically coupled angular trimer and mononuclear inclusion complex

Two new copper(II) complexes, [Cu₃(L¹)₂(H₂O)₂](ClO₄)₂ (1) and [CuL²⊂ (H₂O)] (2) have been derived from two di-compartmental Schiff base ligands H₂L¹ and H₂L², respectively. Depending on slight modification of the substituent group of the potentially N₂O₄ donor ligands, tri- and mononuclear structures are obtained, which have been confirmed by single-crystal X-ray diffraction studies. Both complexes have been characterized by elemental analysis, IR, UV-vis and EPR spectroscopy. Complex 1 consists of an angular trinuclear array of copper ions, while complex 2 consists of a mononuclear copper center. Variable temperature magnetic susceptibility measurements have been performed to investigate the magnetic behaviour of complex 1 and the result indicates a strong antiferromagnetic exchange interaction (J = −120.1(2) cm⁻¹) between the adjacent copper(II) centers through two double μ₂-phenoxo bridges. Complex 2 is a mononuclear inclusion compound encapsulating one water molecule in the vacant external compartment of the ligand through hydrogen-bonding interactions.     

A new sensitive Edman-type reagent: 4-(N-1-dimethylaminonaphthalene-5-sulfonylamino)phenyl isothiocyanate. Its synthesis and application for micro-sequencing of polypeptides

A new fluorescent PITC homologue Edman-type reagent, 4-(N-1-dimethylaminonaphthalene-5-sulfonylamino)phenyl isothiocyanate (DNSAPITC), was synthesized following a simple three-step synthetic route. The reagent was crystallized and characterized by thin-layer chromatography, IR and electron impact mass spectrometry. Reference DNSAPTH-amino acid derivatives were prepared and a two-dimensional chromatography system on micro-polyamide sheets was developed for separating this mixture. On these sheets the sensitivity was 1-5 pmol, by exposure at 366 nm. Model peptides and proteins were subjected to Edman degradations with this new reagent. A similar coupling efficiency and repetitive degradation yield to those of PITC were found with this reagent. The advantages and limitations of this reagent for sensitive microsequencing are discussed.